Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic

Sachin S Goel1, Shikhar Agarwal, E Murat Tuzcu

  • 1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, J2-3, 9500 Euclid Ave, Cleveland, OH 44195, USA. kapadis@ccf.org

Circulation
|January 28, 2012
PubMed

Insights

Percutaneous coronary intervention (PCI) in patients with severe aortic stenosis (AS) shows similar short-term mortality to those without AS. However, patients with low ejection fraction or high surgical risk scores face increased 30-day mortality after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Management of coronary artery disease (CAD) in severe aortic stenosis (AS) is complex, especially with transcatheter aortic valve replacement (TAVR) availability.
  • Outcomes of percutaneous coronary intervention (PCI) in patients with severe AS and CAD are not well-established.
  • This study compares short-term PCI outcomes in patients with and without severe AS.

Purpose of the Study:

  • To compare the short-term outcomes of PCI in patients with and without severe aortic stenosis.
  • To identify risk factors for mortality following PCI in patients with severe AS.

Main Methods:

  • Retrospective analysis of a PCI database from 1998-2008.
  • Inclusion of 254 patients with severe AS and 508 propensity-matched patients without AS who underwent PCI.
  • Primary endpoint: 30-day mortality post-PCI.

Main Results:

  • 30-day mortality after PCI was similar between patients with and without severe AS (4.3% vs. 4.7%, P=0.2).
  • Patients with severe AS and low ejection fraction (≤30%) had significantly higher 30-day mortality (5.4% vs. 1.2%, P<0.001).
  • Patients with severe AS and high Society of Thoracic Surgeons (STS) score (≥10) also had higher 30-day mortality (10.4% vs. 0%, P<0.001).

Conclusions:

  • PCI can be safely performed in patients with severe symptomatic AS and CAD, with no increased short-term mortality compared to controls.
  • Low ejection fraction and high STS score are critical predictors of 30-day mortality post-PCI in severe AS patients.
  • Findings guide management decisions for high-risk severe AS patients undergoing PCI, particularly those considered for TAVR.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
453
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589